Rare diseases
Investigational molecules
Locations
Study on the Safety of GEN1053 Alone and with an Immunomodulator for Patients with Malignant Solid Tumors
SpainStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
BelgiumStudy on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma
BelgiumStudy on Progesterone for Improving Birth Rates in Couples with Unexplained Infertility Undergoing Mild Ovarian Stimulation and Intrauterine Insemination
The NetherlandsStudy of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy
CzechiaStudy of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer
FranceStudy on Amoxicillin and Clavulanic Acid to Prevent Infection in Women with Obstetric Perineal Tear
DenmarkStudy on Metreleptin for Patients with Partial Lipodystrophy
BelgiumLong-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases
BelgiumStudy on the Safety and Effects of Ixodes ricinus Contact Phase Inhibitor in Adults with Spontaneous Brain Bleeding
BelgiumStudy on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis
FranceStudy of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma
DenmarkTell us about your condition – we search every trial in Europe and connect you with the right site.
